340B Antitrust Lawsuit Against Insulin Drugmakers Could Have New Life After Federal Appeals Court Hearing 

A panel of judges heard arguments in a case against four major insulin manufacturers at the U.S. 2nd Circuit Court of Appeals in New York City.
Federal appeals court judges on Friday questioned whether four major insulin manufacturers could have imposed similar 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

HHS to Issue Guidance on 340B Rebates, IRA Interaction Within 30 Days

HHS plans to release stakeholder guidance on 340B rebates in 30 days.
The U.S. Department of Health and Human Services (HHS) plans to release guidance within 30 days on 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court Backs HHS in Dispute Over DSH Calculation, 340B Providers Condemn Decision Which Could Impact Eligibility for Some Hospitals

The Supreme Court sided with federal health officials this week in a dispute over the Disproportionate Share Hospital (DSH) formula.
The U.S. Supreme Court on Tuesday sided against more than 200 hospitals in a dispute over Medicare disproportionate share hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State 340B Contract Pharmacy Lawsuit Roundup: New Filings in Utah

Key briefs were filed recently in state contract pharmacy litigation in Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Federal Judge Grills Both Sides in Key Hearing on 340B Rebate Dispute

A hearing on five drug industry 340B rebate lawsuits took place April 29 in the U.S. District Court for the District of Columbia.
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Holds High-Stakes Hearings Today on Five Drug Industry 340B Rebate Lawsuits

U.S. District Judge Dabney Friedrich of the District of Columbia is presiding over five April 29 hearings over drugmaker 340B rebate lawsuits. She previously largely sided with Novartis and United Therapeutics in a separate case on drugmaker contract pharmacy restrictions.
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Appellate Court Briefings on 340B Laws in West Virginia, Louisiana

Key briefs were filed recently in state contract pharmacy litigation in two federal appeals court.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Continues to Oppose Unapproved Drugmaker 340B Rebate Models in New Legal Filings

HHS has again urged a federal district court to reject multiple drug industry lawsuits seeking to implement 340B rebate models.
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Sues Utah Over New 340B Contract Pharmacy Access Law

A drug industry trade group recently challenged Utah's new 340B contract pharmacy access law in the U.S. District Court for the District of Utah.
An influential drug industry trade group on Friday sued Utah over its 340B contract pharmacy access law, marking the third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck Exempts Three More States from 340B Restrictions, Novartis Sues Utah Over Contract Pharmacy Access Law

Merck recently announced it would exempt additional states from its 340B contract pharmacy restrictions.
Merck is lifting its 340B contract pharmacy restrictions in three more states that have recently enacted contract pharmacy access laws—while [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live